Trial Profile
Opioid Induced Gait Variability
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Tapentadol (Primary) ; Tramadol (Primary)
- Indications Neurologic gait disorders
- Focus Therapeutic Use
- 25 Apr 2017 New trial record